COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,445 Articles (22,835 medRxiv, 8,610 bioRxiv)

Most recent first Previous |  Page 784: Articles 7831-7840  | Next

Profiling of immune responses to COVID-19 and vaccination uncovers potent adjuvant capacities of SARS CoV-2 infection to vaccination leading to memory T cell responses with a Th17 signature in cancer patients
Echaide, M., Labiano, I., Delgado, M., Fernandez de Lascoiti, A., Ochoa, P., Garnica, M., Ramos, P., Chocarro de Erauso, L., Fernandez, L., Arasanz, H., Bocanegra, A., Blanco, E., Pineiro, S., Zuazo, M., Morente, P., Vera, R., Alsina, M., Escors, D., Kochan, G.
10.1101/2022.05.27.22275672 — Posted: 2022-05-27
Demographic and professional risk factors of COVID-19 infections among physicians in low- and middle-income settings; findings from a representative survey in two Brazilian states.
Russo, G., Cassenote, A. J. F., de Oliveira, B. L. C. A., Scheffer, M. C.
10.1101/2022.05.27.22275696 — Posted: 2022-05-27
Epidemiology and role of SARS-CoV-2 Linkage in Paediatric Inflammatory Multisystem Syndrome (PIMS): A Canadian Paediatric Surveillance Program National Prospective Study
El Tal, T., Morin, M.-P., Morris, S., Farrar, D. K., Berard, R. A., Kakkar, F., Moore Hepburn, C., Baerg, K., Beaufils, C., Bennett, T.-L., Benseler, S. M., Beaudoin-Bussieres, G., Chan, K., Cyr, C., Dahdah, N., Donner, E. J., Drouin, O., Edjoc, R., Eljaouhari, M., Embree, J. E., Farrell, C., Finzi, A., Forgie, S., Giroux, R., Kang, K. T., King, M., Laffin Thibodeau, M., Lang, B., Laxer, R. M., Luu, T. M., McCrindle, B. W., Orkin, J., Papenburg, J., Pound, C. M., Price, V. E., Proulx-Gauthier, J.-P., Purewal, R., Sadarangani, M., Salvadori, M. I., Thibeault, R., Top, K. A., Viel-Theriault, I., Haddad, E., Scuccimarri, R., Yeung, R. S.
10.1101/2022.05.27.22275613 — Posted: 2022-05-27
Shared within-host SARS-CoV-2 variation in households
Walter, K. S., Kim, E., Verma, R., Altamirano, J., Leary, S., Carrington, Y. J., Jagannathan, P., Singh, U., Holubar, M., Subramanian, A., Khosla, C., Maldonado, Y., Andrews, J. R.
10.1101/2022.05.26.22275279 — Posted: 2022-05-27
Protection against Omicron conferred by mRNA primary vaccine series, boosters, and prior infection
Chin, E. T., Leidner, D., Lamson, L., Lucas, K., Studdert, D. M., Goldhaber-Fiebert, J. D., Andrews, J. R., Salomon, J. A.
10.1101/2022.05.26.22275639 — Posted: 2022-05-27
SHIVIR - An Agent-Based Model to assess the transmission of COVID-19 in India
M.S., N., John, D., S.P., A., Jammy, G. R., Pant, R., Choudhury, L.
10.1101/2022.05.26.22275624 — Posted: 2022-05-27
A Model-Based Strategy on COVID-19 Vaccine Roll-out in the Philippines
Escosio, R. A. S., Cawiding, O. R., Hernandez, B. S., Mendoza, R. G., Mendoza, V. M. P., Mohammad, R. Z., Pilar-Arceo, C. P. C., Salonga, P. K. N., Suarez, F. L. E., Sy, P. W., Vergara, T. H. M., de los Reyes, A. A.
10.1101/2022.05.27.22275675 — Posted: 2022-05-27
The Glycan-Specificity of the Pineapple Lectin AcmJRL and its Carbohydrate-Dependent Binding of the SARS-CoV-2 Spike Protein
Meiers, J., Dastbaz, J., Adam, S., Rasheed, S., Kirsch, S. H., Meiser, P., Gross, P., Mueller, R., Titz, A.
10.1101/2022.05.27.493400 — Posted: 2022-05-27
Structural basis of a two-antibody cocktail exhibiting highly potent and broadly neutralizing activities against SARS-CoV-2 variants including diverse Omicron sublineages
Li, X., Pan, Y., Yin, Q., Wang, Z., Shan, S., Zhang, L., Yu, J., Qu, Y., Sun, L., Gui, F., Lu, J., Jing, Z., Wu, W., Huang, T., Shi, X., Li, J., Li, X., Li, D., Wang, S., Yang, M., Zhang, L., Duan, K., Liang, M., Yang, X., Wang, X.
10.1101/2022.05.27.493682 — Posted: 2022-05-27
Development and scaling of a sequencing pipeline for genomic surveillance of SARS-CoV-2 in New York City
Hammerling, M. J., Kang, S. C., Ward, W., Escapa, I. F., Bugga, P., Del Castillo, C., Hopkins, M., Chase, S., Rey, S., Law, D., Carpio, A., Nelson, K., Chhabria, S., Gupta, S., Rivera, T., Laurent, J. M., Hao, H., Lee, H. H.
10.1101/2022.05.25.22273991 — Posted: 2022-05-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).